Guangzhou Henovcom Bioscience Co. Ltd.
Quick facts
Phase 1 pipeline
- HNC042 multiple ascending doses
- HNC042 single dose
- HNC1058 Capsules
- HNC364
- HNC364 Injectable Suspension
- HNC664 capsules FED
- HNC664 capsules Single dose
- Rasagiline Tablets
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: